Hep C Treatment for All Genotypes Granted Priority Review

Hep C Treatment for All Genotypes Granted Priority Review “As the first fixed-dose combination of 2 pan-genotypic, direct-acting antivirals, SOF/VEL [sofosbuvir/velpatasvir] represents an important step forward in the treatment of patients with hepatitis C,” said Norbert Bischofberger, executive vice … … Continue reading

Sofosbuvir-velpatasvir successful in hep C regardless of genotype

Sofosbuvir-velpatasvir successful in hep C regardless of genotype (HealthDay)—Sofosbuvir-velpatasvir is effective for hepatitis C virus (HCV), regardless of genotype, according to three studies published online Nov. 17 in the New England Journal of Medicine. The research was published to coincide … Continue reading

'Dallas Buyers' Club' for Hep C treatments under investigation

'Dallas Buyers' Club' for Hep C treatments under investigation A "Dallas Buyers Club" of doctors and patients importing potentially life-saving Hepatitis C medication from countries like China is being investigated by the Therapeutic Goods Administration. Australians suffering Hepatitis C have … Continue reading

Study: Merck hep C combo effective in kidney disease patients

Study: Merck hep C combo effective in kidney disease patients Earlier this year, the FDA granted Merck breakthrough status for its combined grazoprevir/elbasvir combination medication for treatment of hepattis C (HCV). Merck is also targeting patients with severe kidney impairment … Continue reading